These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8582968)

  • 1. Natural cycles for in-vitro fertilization: cost-effectiveness analysis and factors influencing outcome.
    Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA; YoungLai EV
    Hum Reprod; 1995 Jul; 10(7):1719-24. PubMed ID: 8582968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICSI does not increase the cumulative live birth rate in non-male factor infertility.
    Li Z; Wang AY; Bowman M; Hammarberg K; Farquhar C; Johnson L; Safi N; Sullivan EA
    Hum Reprod; 2018 Jul; 33(7):1322-1330. PubMed ID: 29897449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer.
    Teramoto S; Osada H; Sato Y; Shozu M
    Fertil Steril; 2016 Jul; 106(1):113-118. PubMed ID: 27041027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment.
    Bodri D; Kawachiya S; Kondo M; Kato R; Matsumoto T
    Fertil Steril; 2014 Apr; 101(4):1001-7.e2. PubMed ID: 24534290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
    Ji J; Liu Y; Tong XH; Luo L; Ma J; Chen Z
    Hum Reprod; 2013 Oct; 28(10):2728-34. PubMed ID: 23887075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural oocyte retrieval with intravaginal fertilization: a simplified approach to in vitro fertilization.
    Taymor ML; Ranoux CJ; Gross GL
    Obstet Gynecol; 1992 Nov; 80(5):888-91. PubMed ID: 1407935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 15. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CHALLENGING THE OPTIMAL NUMBER OF RETRIEVED OOCYTES AND ITS IMPACT ON PREGNANCY AND LIVE BIRTH RATES IN IVF/ICSI CYCLES].
    Blais I; Lahav-Baratz S; Koifman M; Wiener-Megnazi Z; Auslender R; Dirnfeld M
    Harefuah; 2015 Jun; 154(6):350-5, 406. PubMed ID: 26281076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor responders in IVF: cancellation of a first cycle is not predictive of a subsequent failure.
    Baka S; Makrakis E; Tzanakaki D; Konidaris S; Hassiakos D; Moustakarias T; Creatsas G
    Ann N Y Acad Sci; 2006 Dec; 1092():418-25. PubMed ID: 17308168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
    Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
    Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit of artificial oocyte activation is dependent on the fertilization rate in a previous treatment cycle.
    Montag M; Köster M; van der Ven K; Bohlen U; van der Ven H
    Reprod Biomed Online; 2012 May; 24(5):521-6. PubMed ID: 22417664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of in-vitro fertilization through natural cycles in poor responders.
    Bassil S; Godin PA; Donnez J
    Hum Reprod; 1999 May; 14(5):1262-5. PubMed ID: 10325275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.